Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …

Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

Introduction Women with polycystic ovary syndrome (PCOS) have increased risk of
metabolic syndrome. The relative contribution of clinical, demographic or biochemical …

Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy among women
during reproductive age. PCOS is characterised by hyperandrogenaemia …

Women with polycystic ovary syndrome (PCOS) have a considerable risk of metabolic
dysfunction. This review aims to present contemporary knowledge on obesity, insulin …

Polycystic Ovary Syndrome (PCOS) represents a heterogeneous disorder and, using
Rotterdam diagnostic criteria, four main phenotypes (A, B, C, and D) have been …

Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …

Summary Background and Objective Polycystic ovary syndrome (PCOS) is a common
heterogeneous endocrine disorder associated with metabolic syndrome (MetS). The aim of …

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting
reproductive‐age women. Important factors in its pathogenesis are hyperinsulinaemia and …

The normal function of the female reproductive system is closely linked to energy
homeostasis with the ultimate scope of fertility and human race perpetuation through the …